Latest YHLO News
May 26, 2021
Appleby’s Hong Kong office acted as Cayman Islands and BVI counsel to Shenzhen YHLO Biotech Co., Ltd. (stock code: 688575) (YHLO Biotech) in relation to its listing on the STAR Market of the Shanghai Stock Exchange on 17 May 2021, with proceeds of approximately RMB 606.8 million. YHLO Biotech is a leading company of immunoassay solutions in China, specialised in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents for diagnosis of autoimmune diseases, reproductive health, infectious diseases and others. It was founded in 2008 and is headquartered in Shenzhen China.